These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9218797

  • 1. Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction.
    Aluvihare VR, Khamlichi AA, Williams GT, Adorini L, Neuberger MS.
    EMBO J; 1997 Jun 16; 16(12):3553-62. PubMed ID: 9218797
    [Abstract] [Full Text] [Related]

  • 2. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC, Steele CR, Gu L, Song W, Pierce SK.
    J Immunol; 1999 Jun 15; 162(12):7171-80. PubMed ID: 10358163
    [Abstract] [Full Text] [Related]

  • 3. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
    Forquet F, Barois N, Machy P, Trucy J, Zimmermann VS, Leserman L, Davoust J.
    J Immunol; 1999 Mar 15; 162(6):3408-16. PubMed ID: 10092796
    [Abstract] [Full Text] [Related]

  • 4. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation.
    Kim YM, Pan JY, Korbel GA, Peperzak V, Boes M, Ploegh HL.
    Proc Natl Acad Sci U S A; 2006 Feb 28; 103(9):3327-32. PubMed ID: 16492756
    [Abstract] [Full Text] [Related]

  • 5. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
    Vascotto F, Lankar D, Faure-André G, Vargas P, Diaz J, Le Roux D, Yuseff MI, Sibarita JB, Boes M, Raposo G, Mougneau E, Glaichenhaus N, Bonnerot C, Manoury B, Lennon-Duménil AM.
    J Cell Biol; 2007 Mar 26; 176(7):1007-19. PubMed ID: 17389233
    [Abstract] [Full Text] [Related]

  • 6. Stability of the B cell antigen receptor modulates its signaling and antigen-targeting functions.
    Parent BA, Wang X, Song W.
    Eur J Immunol; 2002 Jul 26; 32(7):1839-46. PubMed ID: 12115602
    [Abstract] [Full Text] [Related]

  • 7. Engagement of B cell receptor regulates the invariant chain-dependent MHC class II presentation pathway.
    Zimmermann VS, Rovere P, Trucy J, Serre K, Machy P, Forquet F, Leserman L, Davoust J.
    J Immunol; 1999 Mar 01; 162(5):2495-502. PubMed ID: 10072488
    [Abstract] [Full Text] [Related]

  • 8. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P, Armandola E, Garbi N, Hämmerling GJ.
    Eur J Immunol; 2003 Feb 01; 33(2):411-21. PubMed ID: 12645938
    [Abstract] [Full Text] [Related]

  • 9. Immune selection in murine tumors. Ph.d thesis.
    Svane IM, Engel AM.
    APMIS Suppl; 2003 Feb 01; (106):1-46. PubMed ID: 12739251
    [Abstract] [Full Text] [Related]

  • 10. B cell receptor-mediated internalization of salmonella: a novel pathway for autonomous B cell activation and antibody production.
    Souwer Y, Griekspoor A, Jorritsma T, de Wit J, Janssen H, Neefjes J, van Ham SM.
    J Immunol; 2009 Jun 15; 182(12):7473-81. PubMed ID: 19494270
    [Abstract] [Full Text] [Related]

  • 11. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway.
    Clark MR, Massenburg D, Siemasko K, Hou P, Zhang M.
    Curr Opin Immunol; 2004 Jun 15; 16(3):382-7. PubMed ID: 15134789
    [Abstract] [Full Text] [Related]

  • 12. B cells extract and present immobilized antigen: implications for affinity discrimination.
    Batista FD, Neuberger MS.
    EMBO J; 2000 Feb 15; 19(4):513-20. PubMed ID: 10675320
    [Abstract] [Full Text] [Related]

  • 13. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.
    Lang P, Stolpa JC, Freiberg BA, Crawford F, Kappler J, Kupfer A, Cambier JC.
    Science; 2001 Feb 23; 291(5508):1537-40. PubMed ID: 11222857
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg).
    Paquin Proulx D, Aubin E, Lemieux R, Bazin R.
    Clin Immunol; 2010 Jun 23; 135(3):422-9. PubMed ID: 20138586
    [Abstract] [Full Text] [Related]

  • 15. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules.
    Amigorena S, Bonnerot C.
    Semin Immunol; 1999 Dec 23; 11(6):385-90. PubMed ID: 10625592
    [Abstract] [Full Text] [Related]

  • 16. Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens.
    Minskoff SA, Matter K, Mellman I.
    J Immunol; 1998 Sep 01; 161(5):2079-83. PubMed ID: 9725196
    [Abstract] [Full Text] [Related]

  • 17. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.
    Mol Immunol; 2009 Dec 01; 47(2-3):164-74. PubMed ID: 19818504
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC, Donachie AM, Mowat AM.
    Eur J Immunol; 2008 May 01; 38(5):1238-46. PubMed ID: 18398931
    [Abstract] [Full Text] [Related]

  • 19. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL, Villiers MB, Marche PN.
    Ann Biol Clin (Paris); 1999 May 01; 57(2):127-35. PubMed ID: 10210739
    [Abstract] [Full Text] [Related]

  • 20. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z, Hofgaard PO, Omholt H, Bogen B.
    Scand J Immunol; 2004 May 01; 60(1-2):143-52. PubMed ID: 15238083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.